1-4 of 4
Hitoshi Sase
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Selective TRK Inhibitor CH7057288 against TRK Fusion-Driven Cancer

Hiroshi Tanaka, Hitoshi Sase, Toshiyuki Tsukaguchi, Masami Hasegawa, Hiromi Tanimura, Miyuki Yoshida, Kiyoaki Sakata, Toshihiko Fujii, Yukako Tachibana, Kenji Takanashi, Atsuko Higashida, Kiyoshi Hasegawa, Yoshiyuki Ono, Nobuhiro Oikawa, Toshiyuki Mio
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (12): 2519–2529.
https://doi.org/10.1158/1535-7163.MCT-17-1180
Published: 03 December 2018
View article titled, Selective TRK Inhibitor CH7057288 against TRK Fusion-Driven Cancer
Open the PDF for Selective TRK Inhibitor CH7057288 against TRK Fusion-Driven Cancer in another window
Includes: Supplementary data
Journal Articles

Acquired JHDM1D–BRAF Fusion Confers Resistance to FGFR Inhibition in FGFR2-Amplified Gastric Cancer

Hitoshi Sase, Yoshito Nakanishi, Satoshi Aida, Kana Horiguchi-Takei, Nukinori Akiyama, Toshihiko Fujii, Kiyoaki Sakata, Toshiyuki Mio, Masahiro Aoki, Nobuya Ishii
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (10): 2217–2225.
https://doi.org/10.1158/1535-7163.MCT-17-1022
Published: 01 October 2018
View article titled, Acquired JHDM1D–BRAF Fusion Confers Resistance to FGFR Inhibition in <em>FGFR2</em>-Amplified Gastric Cancer
Open the PDF for Acquired JHDM1D–BRAF Fusion Confers Resistance to FGFR Inhibition in <em>FGFR2</em>-Amplified Gastric Cancer in another window
Includes: Supplementary data
Journal Articles

ERK Signal Suppression and Sensitivity to CH5183284/Debio 1347, a Selective FGFR Inhibitor

Yoshito Nakanishi, Hideaki Mizuno, Hitoshi Sase, Toshihiko Fujii, Kiyoaki Sakata, Nukinori Akiyama, Yuko Aoki, Masahiro Aoki, Nobuya Ishii
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2015) 14 (12): 2831–2839.
https://doi.org/10.1158/1535-7163.MCT-15-0497
Published: 06 December 2015
View article titled, ERK Signal Suppression and Sensitivity to CH5183284/Debio 1347, a Selective FGFR Inhibitor
Open the PDF for ERK Signal Suppression and Sensitivity to CH5183284/Debio 1347, a Selective FGFR Inhibitor in another window
Includes: Supplementary data
Journal Articles

The Fibroblast Growth Factor Receptor Genetic Status as a Potential Predictor of the Sensitivity to CH5183284/Debio 1347, a Novel Selective FGFR Inhibitor

Yoshito Nakanishi, Nukinori Akiyama, Toshiyuki Tsukaguchi, Toshihiko Fujii, Kiyoaki Sakata, Hitoshi Sase, Takehito Isobe, Kenji Morikami, Hidetoshi Shindoh, Toshiyuki Mio, Hirosato Ebiike, Naoki Taka, Yuko Aoki, Nobuya Ishii
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2014) 13 (11): 2547–2558.
https://doi.org/10.1158/1535-7163.MCT-14-0248
Published: 03 November 2014
View article titled, The Fibroblast Growth Factor Receptor Genetic Status as a Potential Predictor of the Sensitivity to CH5183284/Debio 1347, a Novel Selective FGFR Inhibitor
Open the PDF for The Fibroblast Growth Factor Receptor Genetic Status as a Potential Predictor of the Sensitivity to CH5183284/Debio 1347, a Novel Selective FGFR Inhibitor in another window
Includes: Supplementary data